← Browse by Condition
Medical Condition
renal cell carcinoma
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 3, Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for renal cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — renal cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for renal cell carcinoma?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for renal cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for renal cell carcinoma?
renal cell carcinoma research spans Phase 1 (1 trial), Phase 2 (6 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a renal cell carcinoma clinical trial?
Eligibility criteria for renal cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 6
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05770037 Phase 2, Phase 3
Recruiting
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT07124000
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
NCT05319015 Phase 2
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT05969496 Phase 2
Recruiting
Enrollment
17 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07397611 Phase 2
Recruiting
Enrollment
32 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT05641935 Phase 2
Recruiting
Enrollment
210 pts
Location
United States
Sponsor
john eisenbrey
NCT06265025 Phase 1, Phase 2
Recruiting
Enrollment
125 pts
Location
South Korea
Sponsor
GeneMedicine Co., Ltd.
NCT07326280
Recruiting
Enrollment
310 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06770855
Recruiting
Enrollment
23 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn...
NCT03288532 Phase 3
Recruiting
Enrollment
1,750 pts
Location
United Kingdom
Sponsor
University College, London
NCT06101290
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
University of California, Davi...
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology